Cuprymina, copper (64Cu) chloride

Description

Cuprymina is a solution of copper (64Cu) chloride. 

Indication 

Cuprymina is a radiopharmaceutical precursor. It is not intended for direct use in patients. This medicinal product must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide. 

Summary of Product Characteristics (SmPC)  

Denmark   Estonia  Finland  Iceland  Latvia  Lithuania  Norway  Sweden

Practical information about Cuprymina

The marketing authorisation holder for Cuprymina is A.C.O.M, distributed in the Nordic and Baltic regions by SAM Nordic.

Further information about this medicinal product can be obtained from the representative of the marketing authorisation holder: SAM Nordic, Tel: +46 8 720 58 22, info@samnordic.se